Lion's Mane
In short
Summary of findings for quick reference
Lion's Mane (Hericium erinaceus) is an East Asian medicinal and culinary mushroom with a modest, well-defined tradition. In China it is hou tou gu, the monkey head mushroom, recorded in the classical materia medica and used as a gentle digestive tonic for the spleen and the stomach, almost always eaten as a food rather than taken as a strong medicinal preparation. In Japan it is yamabushitake, the mountain monk mushroom, prized in cuisine and Buddhist temple cooking for its delicate, seafood-like texture. The species also grows wild in European temperate forests, Austria included, but it is not a documented European household remedy.
The popular picture of Lion's Mane as a brain or nerve aid is a modern development, not part of the old tradition. It grew out of Japanese laboratory research from the early 1990s, when Kawagishi isolated the hericenones from the fruit body and the erinacines from the mycelium and reported that they induce nerve growth factor in cell and animal models. There is no European Medicines Agency monograph, no German Commission E entry, and no pharmacopoeial registration for this mushroom. The documented tradition is about the stomach and digestion, and the cognitive framing should be read as recent science rather than as inherited tradition.
The modern clinical evidence is small and exploratory. The most cited human study, Mori and colleagues in 2009, was a small pilot in older Japanese adults with mild cognitive impairment, and the reported effect faded once supplementation stopped. The laboratory nerve growth factor findings are interesting but the link to any clear effect in healthy people is not established. Lion's Mane is most honestly understood as a traditional East Asian food and digestive mushroom with an emerging, unsettled evidence base, not as a clinical treatment for cognition.
Clinical evidence ↔ Historical significanceWe display two separate evidence categories: clinical evidence from modern trials and historical significance from documented healing tradition. Both are valuable, but they answer different questions.Read more
In every encyclopedia entry we evaluate two distinct categories of evidence. Clinical evidence as used in trials meets a narrower but scientifically essential bar. At the same time, the hundreds of thousands of plant species worldwide have only partially been captured and tested in modern studies.
Alongside the trial picture our researchers compile a comprehensive overview of where and since when a plant has been used across different traditions of natural medicine. When a plant has been used as a medicinal plant in many cultures across many generations, that historical significance deserves to be visible too.
Our position: a truly informative overview emerges only when both categories sit side by side. We communicate transparently what counts as what.
Overview
Lion's Mane (Hericium erinaceus) is a distinctive medicinal mushroom of the family Hericiaceae. The fruit body is unmistakable: a cream-white globular cushion hanging from dead or dying hardwood, covered in long, soft, icicle-like spines. The German common name Igel-Stachelbart (hedgehog beard) captures the same look from another angle. In East Asia the mushroom carries the Chinese name Hou Tou Gu, monkey head mushroom, a culinary as well as a medicinal staple.
The mushroom contains two named groups of bioactive compounds: hericenones, isolated from the fruit body, and erinacines, isolated from the mycelium. Both have shown nerve growth factor induction in laboratory work. Whether that laboratory finding translates into any clinical effect in healthy people is not established. There is no EMA HMPCEuropean Medicines Agency, Committee on Herbal Medicinal Products (HMPC) monograph for Lion's Mane and no permitted EFSA health claim. Modern human evidence is small and exploratory, mostly small pilot trials, and the entry treats it accordingly.
History
Lion's Mane has been used in traditional Chinese medicine for centuries under the name Hou Tou Gu (猴头菇), monkey head mushroom. The classical TCM use is constitutional, framed around the stomach and the spleen rather than around cognition, and the mushroom enters most often as a food, not as a strong medicinal preparation. Japanese cuisine and Buddhist temple cooking use the fresh fruit body for its delicate, seafood-like texture; the Japanese name Yamabushitake refers to the mountain ascetics whose pleated robes the mushroom resembles.
Lion's Mane is also native to European temperate forests, Austria included. It grows wild on the wounds and decay sites of old beech, oak, and maple in central European hardwood forests, although fruit bodies are rare and the species is locally protected in several regions, Austria among them. It is not an established Austrian or central European Hausmittel; the home-remedy and Hildegard canon do not include it. Western interest is a late twentieth century arrival, driven by the laboratory work on nerve growth factor and by Japanese culinary traditions reaching the wider supplement market.
Mechanism
Two named bioactive groups define the modern mechanistic story. Hericenones are aromatic compounds isolated from the fruit body. Erinacines are diterpene compounds isolated from the mycelium. Both groups have shown induction of nerve growth factor (NGF) in cultured cells in laboratory work. NGF is a signalling protein involved in the maintenance and survival of certain neuron populations; this is the mechanistic story that drives most of the supplement-market framing of Lion's Mane.
It is important to be honest about what the NGF literature does and does not show. The induction of nerve growth factor by hericenones and erinacines has been observed in cell culture and in animal models. Whether that laboratory finding translates into a clinically meaningful effect in healthy people taking a supplement is not established. The supplement-marketing phrases that Lion's Mane improves memory or is neuroprotective overreach the available evidence and are not used here. The mushroom is best read as a traditional East Asian food and medicinal with an interesting but underdetermined modern mechanistic story.
Modern clinical research on Lion's Mane is small and exploratory. Mori and colleagues published a 2009 randomised pilot trial in Japanese adults with mild cognitive impairment, reporting an improvement on a cognitive scale over sixteen weeks with three grams per day of dried Lion's Mane in tablet form; the trial enrolled a small number of participants and the benefit faded after the supplementation stopped. Saitsu and colleagues published a 2019 small randomised trial in healthy older Japanese adults, reporting modest improvements on a brief cognitive screen with a similar daily dose. Nagano and colleagues published a 2010 small randomised pilot in women with menopausal symptoms, reporting reductions in irritability and anxiety scores over four weeks.
These trials are small in scale, short in duration, and conducted with different product forms and outcome measures. There is no EMA HMPCEuropean Medicines Agency, Committee on Herbal Medicinal Products (HMPC) monograph for Lion's Mane. The EFSA has not granted a permitted health claim. The honest reading is that the modern evidence base is interesting and directionally consistent in a few small studies, but too thin and too heterogeneous to support strong claims. Lion's Mane is sold in Europe as a food supplement under Novel Food rules and general supplement law, without an EU-level traditional-use indication.
Evidence
| Outcome | Class | Grade | Effect | Studies |
|---|---|---|---|---|
| Cognitive scores in mild cognitive impairmentMori et al. 2009 small randomised pilot trial in Japanese adults with mild cognitive impairment reported a modest improvement on a cognitive scale over sixteen weeks with three grams per day of dried Lion's Mane in tablet form. The effect faded after supplementation stopped. Small sample size, short duration, single trial.Japanese adults with mild cognitive impairment | EmergingEmerging research. Early small trials suggest an effect but await replication. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Preliminary Signal | |
| Nerve growth factor (NGF) induction in vitroHericenones (fruit body) and erinacines (mycelium) have been reported to induce NGF in cell culture and in animal models. The link between this laboratory finding and any clinical effect in healthy people is not firmly established.Cell culture and animal models | TraditionalTraditional use. Long-standing folk practice or EMA HMPC traditional-use monograph. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Lab Findings, Clinical Unclear | |
| Traditional Chinese medicinal and culinary useHou Tou Gu (monkey head mushroom) has been used in TCM and East Asian cuisine for centuries, traditionally framed around the stomach and the spleen rather than around cognition. Consistent tradition; small modern evidence base.Traditional East Asian populations | TraditionalTraditional use. Long-standing folk practice or EMA HMPC traditional-use monograph. | CEvidence quality grade C. Mixed or limited evidence. Small trials, signals, or traditional use under an EMA HMPC traditional-use monograph. This is an evidence rating, not a product endorsement. | Long Tradition | |
| Menopausal symptoms (irritability, anxiety)Nagano et al. 2010 small randomised pilot in women with menopausal symptoms reported reductions in irritability and anxiety scores over four weeks. Small sample, short duration, single trial.Women with self-reported menopausal symptoms | EmergingEmerging research. Early small trials suggest an effect but await replication. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Preliminary Signal |
Usage
Forms and preparation
Two preparations matter, and the choice between them is the most important practical decision. Fruit body extracts contain hericenones. Mycelium extracts contain erinacines. Both groups have been studied in the NGF literature, but the supplement market has long sold mycelium-on-grain products that contain a great deal of grain substrate and relatively little active mushroom material. A dual extract that combines fruit body and mycelium, both extracted by hot water and by alcohol and recombined, is the most thorough preparation and the one that best reflects the two-part bioactive chemistry. The fresh mushroom is also a fine culinary ingredient, with a tender, seafood-like texture. Sauté in butter or oil over moderate heat until the edges are golden. Dried fruit body can be powdered and stirred into soups or hot drinks. For supplement use, capsules and dual extract powders are the most common modern forms. If you buy a supplement, read the label closely: the part used (fruit body, mycelium, or both) and the extraction method (hot water, alcohol, or dual) should be declared.
Dosage
Most modern trials and supplement labels sit in the range of five hundred to three thousand milligrams of extract per day, with one gram per day a common middle ground. The Mori 2009 cognitive pilot used three grams per day of dried Lion's Mane in tablet form. The Saitsu 2019 trial used a similar daily dose. Supplement extracts are usually more concentrated than dried mushroom, so a one gram per day extract dose is in the same general ballpark as the three gram per day dried mushroom dose used in research. Start at the lower end of the range and take with food. Allow several weeks before judging. The Mori 2009 trial ran for sixteen weeks; the Saitsu 2019 trial ran for twelve weeks. No established upper safe dose exists for long-term use and trials longer than a few months are not available. If you cook with the fresh mushroom, the culinary amount is not a research-defined dose and there is no need to count it as one.
Safety
Look-alikes
Toxic look-alikes
Hericium americanum und Hericium coralloides
Hericium americanum and Hericium coralloides are close relatives in the same genus and also possible in central Europe. Both are edible and not toxic, so they pose no health risk; they simply look different from Hericium erinaceus. Both grow as a branched, coral-like or shrub-like fruit body with multiple arms and shorter spines, while Hericium erinaceus forms a single, unbranched, globular cushion with long cascading spines. If you are looking for the classical Lion's Mane, look for the single, unbranched, globular fruit body.
FAQs
Does Lion's Mane grow in Austria?
Yes. Hericium erinaceus is also native to central European temperate forests, Austria included, and occurs in old beech-dominated hardwood forests on wounds and decay sites of beech, oak, and maple. Finds are rare and the species is locally protected in several Austrian regions. It is not an established Austrian Hausmittel; the German-speaking home-remedy canon does not include it. If you collect from the wild, check the regional protection rules first, and otherwise use cultivated fruit bodies.
Fruit body or mycelium: which is better?
Each contains a different group of bioactive compounds. Hericenones are isolated from the fruit body, erinacines from the mycelium. Both groups have shown NGF induction in laboratory work. The supplement market has long sold mycelium-on-grain products that contain a great deal of grain substrate and relatively little active mushroom material. When you buy a product, look for either a fruit body extract or a true dual extract of fruit body and mycelium combined. Leave plain mycelium-on-grain products on the shelf.
What is NGF and does Lion's Mane make my brain better?
NGF is nerve growth factor, a signalling protein involved in the maintenance and survival of certain neuron populations. In cell culture and animal models, hericenones and erinacines, the two bioactive groups in Lion's Mane, induce an increase in NGF. This is the mechanistic story behind most of the supplement-market positioning of the mushroom. Whether that laboratory finding translates into a measurable cognitive improvement in healthy people is not established. Phrases like the mushroom improves memory or is neuroprotective overreach the available evidence; the small clinical trials show early signals but are too small and too short to support strong claims. Treat it most honestly as a traditional medicinal mushroom with an interesting but underdetermined modern story.
How long should I take Lion's Mane before judging whether anything is happening?
Allow at least several weeks, similar to the available clinical trials. The Mori 2009 pilot trial ran for sixteen weeks; the Saitsu 2019 trial ran for twelve weeks. A perceptible effect in the first few days is not expected and is not described in the research. Start at the lower end of the dose range (around five hundred milligrams to one gram of extract per day) with food and keep a short journal; after eight to twelve weeks you can make an honest assessment of whether you notice a difference. No established upper safe dose for long-term use exists and trials longer than a few months are not available.
Legal notice: The depiction of historical significance and traditional use is context within our encyclopedia and not a health claim for any product, not a treatment promise, and not a substitute for medical advice. What may be stated on product labels, product pages, or in advertising is governed by the applicable legal requirements.